Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
180 hedge funds and large institutions have $665M invested in Meridian Bioscience Inc in 2016 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 62 increasing their positions, 53 reducing their positions, and 20 closing their positions.
50% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 20
17% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 53
4% more funds holding
Funds holding: 173 → 180 (+7)
8% less capital invested
Capital invested by funds: $726M → $665M (-$61.4M)
38% less call options, than puts
Call options by funds: $665K | Put options by funds: $1.07M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$7.75M |
| 2 |
DGI
Discovery Group I
Chicago,
Illinois
|
+$5.98M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$5.13M |
| 4 |
DIA
Dean Investment Associates
Beavercreek,
Ohio
|
+$4.52M |
| 5 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
+$3.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$26.1M |
| 2 |
ICOM
Investment Counselors of Maryland
Baltimore,
Maryland
|
-$4.17M |
| 3 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
-$3.9M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.59M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.25M |
VIVO Hedge Fund Activity: Q4 2016 in Review
180 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q4 2016, worth a combined $665M — down 8.5% from $726M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new VIVO positions and 20 closed out — a net gain of 10 holders — while 62 added to existing stakes and 53 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $7.75M. The largest seller was T. Rowe Price Associates, cutting an estimated $26.1M.
- 180 institutional investors held Meridian Bioscience Inc (VIVO) as of Q4 2016, up from 173 in Q3 2016.
- Funds reported $665M of Meridian Bioscience Inc stock for Q4 2016, down 8.5% quarter-over-quarter.
- 30 funds opened new Meridian Bioscience Inc positions in Q4 2016 and 20 closed out, a net change of +10 holders.
- The largest Meridian Bioscience Inc buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $7.75M added.
- The largest Meridian Bioscience Inc seller in Q4 2016 was T. Rowe Price Associates, an estimated $26.1M sold.
Based on aggregated 13F filings for Q4 2016.